Abstract
There has been minimal practice change in the routine management of neonatal hyperbilirubinemia since the adoption of the 2004 clinical practice guidelines on the management of hyperbilirubinemia in late preterm and term newborns by the American Academy of Pediatrics. In this chapter we discuss five practice changes that are areas of active research. Each is an attempt to improve our approach to the management of neonatal hyperbilirubinemia.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Neonatology Questions and Controversies: Hematology and Transfusion Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.